April 8, 2026
Willkie advised Synsus, a portfolio company of Crescentia Capital, on its acquisition of Emerald Bioagriculture, an innovator in biostimulant technologies.
Synsus, an industry leader renowned for delivering end-to-end, custom-formulated solutions to agricultural, turf, and consumer lawn & garden brands and retailers globally, recently announced the acquisition of Emerald Bioagriculture. This strategic move is set to expand Synsus’ diverse portfolio of technologies to drive the advancement of eco-friendly solutions for growers, turf managers, and homeowners worldwide.
Crescentia Capital is the equity buyout business of Calvert Street Investment Partners.
The Willkie team was led by Willkie partners Neil Townsend and Aaron Savella.
